Calluna Pharma
0866.397.070 · rovalta.com · 09/11/2026
Calluna Pharma
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCalluna Pharma is a Private limited company incorporated in 2004. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Hoogstraten.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0866.397.070
- Incorporation
- 16/07/2004
- Legal form
- Private limited company
- Registered office
- Witherenweg 54
2322 Hoogstraten · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -31,2 k € | -3.2% | -30,2 k € | -242% | 21,3 k € | -58.6% | 51,4 k € | -8.1% | 56 k € |
| EBITDA | -32,6 k € | +18.6% | -40 k € | -294% | 20,6 k € | -59.2% | 50,5 k € | -7.9% | 54,9 k € |
| Operating result | -32,6 k € | +18.6% | -40 k € | -294% | 20,6 k € | -59.2% | 50,5 k € | -7.9% | 54,9 k € |
| Net result | -32,5 k € | +18.3% | -39,7 k € | -356% | 15,5 k € | -58.6% | 37,5 k € | -8.6% | 41 k € |
| Balance sheet | |||||||||
| Equity | 70,3 k € | -31.6% | 102,7 k € | -27.9% | 142,4 k € | +12.2% | 126,9 k € | +41.9% | 89,5 k € |
| Total assets | 73,2 k € | -30.7% | 105,6 k € | -32.4% | 156,3 k € | +13.7% | 137,6 k € | +47.6% | 93,2 k € |
| Cash | 66 k € | -33.4% | 99 k € | -36.7% | 156,3 k € | +179% | 56,1 k € | -36.6% | 88,4 k € |
| Debts | 3 k € | +1.8% | 2,9 k € | -79.0% | 13,9 k € | +30.6% | 10,6 k € | +186% | 3,7 k € |
| Other | |||||||||
| Workforce | – | 0,0 ETP | 0,0 ETP | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/01/2018Manager01/01/2018 → 2019 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Erwin Embrechts | Manager16/07/2004 → 18/06/2016 | ||
Jan Emrechts | Director16/07/2004 → 31/03/2022 |
Other companies at this address
Witherenweg 54 2322 Hoogstraten| Company | CBE no. |
|---|---|
KEMIA● Active | 0555.976.383 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/06/2026 | 24/06/2025 | 18/06/2024 | 03/07/2023 | 30/06/2022 | 07/06/2021 |
| General meeting | 27/05/2026 | 28/05/2025 | 29/05/2024 | 21/06/2023 | 25/05/2022 | 26/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 27/05/2026 | 22/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 28/05/2025 | 24/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 29/05/2024 | 18/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 21/06/2023 | 03/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 25/05/2022 | 30/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 26/05/2021 | 07/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 27/05/2020 | 24/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 29/05/2019 | 11/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 30/05/2018 | 22/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 31/05/2017 | 06/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 25/05/2016 | 26/05/2016 | Dutch | |
| Abridged model | 31/12/2014 | 27/05/2015 | 18/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 28/05/2014 | 16/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 29/05/2013 | 15/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 30/05/2012 | 30/05/2012 | Dutch | |
| Abridged model | 31/12/2010 | 25/05/2011 | 01/06/2011 | Dutch | |
| Abridged model | 31/12/2009 | 26/05/2010 | 28/05/2010 | Dutch | |
| Abridged model | 31/12/2008 | 27/05/2009 | 16/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 28/05/2008 | 04/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 30/06/2007 | 03/07/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/01/2018Manager01/01/2018 → 2019 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Erwin Embrechts | Manager16/07/2004 → 18/06/2016 | ||
Jan Emrechts | Director16/07/2004 → 31/03/2022 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office23/01/2025Zetel (zetelverplaatsing)
- Mandates12/04/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Mandates06/02/2018ONTSLAGEN - BENOEMINGEN
- Mandates05/01/2017Ontslag en benoeming zaakvoerder Î
- Other04/04/2008Adreswijziging
- Other27/07/2004RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Witherenweg 54, 2322 MinderhoutCurrent | accounts 2024 → 2025 | Accounts 2025 · 2026-00183741 |
| Treslong 34, 2322 Minderhout | accounts 2021 → 2023 | Accounts 2023 · 2024-00139499 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Calluna PharmaCurrent | accounts 2006 → 2025 | Accounts 2025 · 2026-00183741 |
Events
- 2025Annual accounts 2025-32,5 k €↑
- 2024Annual accounts 2024-39,7 k €↓
- 2023Annual accounts 202315,5 k €↓
- 2022Annual accounts 202237,5 k €↓
- 2021Annual accounts 202141 k €↑
- 2020Annual accounts 202018,3 k €↓
- 2019Annual accounts 201956,3 k €↑
- 2018Annual accounts 20189,5 k €↓
- 2017Annual accounts 201787,4 k €↓
- 2016Annual accounts 201696,6 k €↑
- 2015Annual accounts 201575,9 k €↓
- 2014Annual accounts 201484 k €↑
- 2013Annual accounts 20139,3 k €↓
- 2012Annual accounts 2012240,9 k €↓
- 2011Annual accounts 2011260,4 k €↑
- 2010Annual accounts 2010210,1 k €↓
- 2009Annual accounts 2009237,3 k €↑
- 2008Annual accounts 200896 k €↑
- 2007Annual accounts 2007-5,8 k €↓
- 2006Annual accounts 2006-5,5 k €
- 16/07/2004IncorporationPrivate limited company